- This meeting has passed.
ANCO’s Hematologic Malignancies Update 2022
September 17, 2022 @ 8:00 am - 12:30 pm
The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses.
The program takes place in :
Sacramento on September 17th
San Francisco on November 12th
Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm.
ANCO acknowledges the support of Adaptive Biotechnologies, ADC Therapeutics, Amgen, Beigene, Incyte Corporation, Kite Pharma, Merck, Sanofi Aventis, SeaGen, and Secura Bio in making this program possible.
Attendance is limited to the first 50 health care professionals per location.
“As an oncologist practicing in a small group of five physicians, I need to stay informed of major developments in the business of oncology in order to effectively manage our practice. ANCO does an amazing job in sharing best practices and providing relevant, timely information. I also applaud ANCO for being the voice of Northern California Oncologists in its governmental advocacy work, which I have seen firsthand as a board member. Every oncologist in our region should be an ANCO member to continue to fortify our mission of providing quality care to all.”
Brad Ekstrand, MD
California Cancer Care